Interestingly, c-Fos was also identified as a candidate MAPK pathway inhibitor resistance gene in near genome-scale ORF/cDNA screens and its overexpression promoted melanoma cell resistance to RAF, MEK, and ERK inhibitors (48). This evidence concerns the gene FOS and melanoma.